» Articles » PMID: 31757879

Whole-Slide Image Analysis Reveals Quantitative Landscape of Tumor-Immune Microenvironment in Colorectal Cancers

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2019 Nov 24
PMID 31757879
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Despite the well-known prognostic value of the tumor-immune microenvironment (TIME) in colorectal cancers, objective and readily applicable methods for quantifying tumor-infiltrating lymphocytes (TIL) and the tumor-stroma ratio (TSR) are not yet available.

Experimental Design: We established an open-source software-based analytic pipeline for quantifying TILs and the TSR from whole-slide images obtained after CD3 and CD8 IHC staining. Using a random forest classifier, the method separately quantified intraepithelial TILs (iTIL) and stromal TILs (sTIL). We applied this method to discovery and validation cohorts of 578 and 283 stage III or high-risk stage II colorectal cancers patients, respectively, who were subjected to curative surgical resection and oxlaliplatin-based adjuvant chemotherapy.

Results: Automatic quantification of iTILs and sTILs showed a moderate concordance with that obtained after visual inspection by a pathologist. The K-means-based consensus clustering of 197 TIME parameters that showed robustness against interobserver variations caused colorectal cancers to be grouped into five distinctive subgroups, reminiscent of those for consensus molecular subtypes (CMS1-4 and mixed/intermediate group). In accordance with the original CMS report, the CMS4-like subgroup (cluster 4) was significantly associated with a worse 5-year relapse-free survival and proved to be an independent prognostic factor. The clinicopathologic and prognostic features of the TIME subgroups have been validated in an independent validation cohort.

Conclusions: Machine-learning-based image analysis can be useful for extracting quantitative information about the TIME, using whole-slide histopathologic images. This information can classify colorectal cancers into clinicopathologically relevant subgroups without performing a molecular analysis of the tumors.

Citing Articles

Automated deep learning-based assessment of tumour-infiltrating lymphocyte density determines prognosis in colorectal cancer.

Millward J, He Z, Nibali A, Mouradov D, Mielke L, Tran K J Transl Med. 2025; 23(1):298.

PMID: 40065354 PMC: 11892243. DOI: 10.1186/s12967-025-06254-3.


From morphology to single-cell molecules: high-resolution 3D histology in biomedicine.

Xu X, Su J, Zhu R, Li K, Zhao X, Fan J Mol Cancer. 2025; 24(1):63.

PMID: 40033282 PMC: 11874780. DOI: 10.1186/s12943-025-02240-x.


Artificial intelligence (AI) for tumor microenvironment (TME) and tumor budding (TB) identification in colorectal cancer (CRC) patients: A systematic review.

Lobanova O, Kolesnikova A, Ponomareva V, Vekhova K, Shaginyan A, Semenova A J Pathol Inform. 2024; 15:100353.

PMID: 39712977 PMC: 11662261. DOI: 10.1016/j.jpi.2023.100353.


Prognostic and predictive value of pathohistological features in gastric cancer and identification of SLITRK4 as a potential biomarker for gastric cancer.

Zhang Y, Xue Y, Gao Y, Zhang Y Sci Rep. 2024; 14(1):29241.

PMID: 39587240 PMC: 11589652. DOI: 10.1038/s41598-024-80292-7.


The combination of CDX2 expression status and tumor-infiltrating lymphocyte density as a prognostic factor in adjuvant FOLFOX-treated patients with stage III colorectal cancers.

Lee J, Park H, Jin H, Jin L, Yoo S, Cho N J Pathol Transl Med. 2024; 59(1):50-59.

PMID: 39440351 PMC: 11736276. DOI: 10.4132/jptm.2024.09.26.